Study seeks clues to breathing problems in myeloma drug
NCT ID NCT04827563
First seen Mar 05, 2026 · Last updated Apr 29, 2026 · Updated 8 times
Summary
This study looked at why some people with multiple myeloma develop shortness of breath when taking the drug carfilzomib. Researchers used an FDA-approved device to check blood vessel health and see if it relates to breathing problems. The goal was to find ways to predict and prevent this side effect. The study was stopped early, but it may still provide useful information.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIOTOXICITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Chicago
Chicago, Illinois, 60637, United States
Conditions
Explore the condition pages connected to this study.